CCDC155 activators are primarily chemicals that can modulate the activity of coiled-coil domain proteins either directly or indirectly. Their primary action points encompass various cellular signaling pathways and molecules with relations to coiled-coil domain proteins. One of the common modulating agents is the cGMP analog, 8-Br-cGMP, which is recognized for activating protein kinase G (PKG). In turn, PKG has been known to play a role in influencing coiled-coil domain proteins' activities, as well as their downstream signaling. Similarly, Okadaic Acid, a serine/threonine phosphatase, can alter the phosphorylation status of coiled-coil domain proteins, impacting their function.
Another significant pathway involves protein kinase C (PKC). PMA, an activator for PKC, stimulates its activity, which can, in turn, regulate coiled-coil domain proteins. This suggests implications for CCDC155. PKA is yet another kinase that can affect coiled-coil domain proteins, and its activation can be achieved using Dibutyryl-cAMP, a cAMP analog. On the same note, elevating intracellular cAMP levels using IBMX can also impact coiled-coil domain protein-mediated signaling. From a different perspective, calcium signaling, being one of the most pivotal intracellular signaling mechanisms, holds relevance. Agents like BAPTA-AM and A23187, which modify intracellular calcium levels, play roles in influencing coiled-coil domain proteins. Calcium ionophores, for instance, increase intracellular calcium levels, modulating CCDC155 and similar proteins. Additionally, pathways like JNK, which can be activated using Anisomycin, hold relevance for coiled-coil domain proteins. The NF-κB pathway, modified using agents like BAY 11-7082, and the Rho signaling pathway, influenced using Y-27632, can have implications for coiled-coil domain protein activity. In a broader context, these activators offer a spectrum of opportunities to modulate coiled-coil domain proteins like CCDC155 by targeting various associated pathways or molecules. The interconnectedness of these pathways underscores the significance of understanding the nuances of each chemical's specific action to tailor interventions for CCDC155's functional modulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $102.00 $347.00 | 7 | |
cGMP analog known to activate protein kinase G (PKG). PKG can influence coiled-coil domain proteins' activity and downstream signaling. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Serine/threonine phosphatase inhibitor. By inhibiting these phosphatases, it can modify the phosphorylation status of coiled-coil domain proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PKC activator that stimulates protein kinase C (PKC). PKC can regulate coiled-coil domain proteins, potentially affecting CCDC155's function. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
cAMP analog known to activate protein kinase A (PKA). PKA can influence coiled-coil domain proteins' activity and their associated signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates the JNK pathway, which can be involved in the regulation of coiled-coil domain proteins and their associated signaling cascades. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Intracellular calcium chelator. By modifying intracellular calcium levels, it can influence signaling pathways associated with coiled-coil domain proteins. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore that increases intracellular calcium levels. Calcium signaling can influence the function of coiled-coil domain proteins like CCDC155. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB pathway inhibitor. Since NF-κB can interact with various proteins, modifying this pathway can influence coiled-coil domain proteins. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
Activates LPA receptors, which can have implications on various signaling cascades and might impact coiled-coil domain proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Elevates intracellular cAMP levels, potentially influencing coiled-coil domain protein-mediated signaling through PKA activation. |